Type 3 Diabetes and Its Role Implications in Alzheimer's Disease

被引：212
作者：
Thuy Trang Nguyen [1 ]
Qui Thanh Hoai Ta [2 ]
Thi Kim Oanh Nguyen [3 ]
Thi Thuy Dung Nguyen [4 ]
Vo Van Giau [5 ,6 ]
机构：
[1] Ho Chi Minh City Univ Technol HUTECH, Fac Pharm, Ho Chi Minh City 700000, Vietnam
[2] Duy Tan Univ, Inst Res & Dev, Danang 550000, Vietnam
[3] Ho Chi Minh City Univ Food Ind, Fac Food Sci & Technol, Ho Chi Minh City 700000, Vietnam
[4] Nguyen Tat Thanh Univ, Fac Environm & Food Engn, Ho Chi Minh City 700000, Vietnam
[5] Gachon Univ, Dept Ind & Environm Engn, Grad Sch Environm, 1342 Sungnam Daero, Seongnam Si 461701, Gyeonggi Do, South Korea
[6] Gachon Univ, Gachon Med Res Inst, Dept Bionano Technol, 1342 Sungnam Daero, Seongnam Si 461701, Gyeonggi Do, South Korea
来源：
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES | 2020年 / 21卷 / 09期
基金：
新加坡国家研究基金会;
关键词：
Alzheimer's disease; hypometabolism; type; 2; diabetes; 3; insulin resistance; AMYLOID PRECURSOR PROTEIN; BRAIN INSULIN-RESISTANCE; CEREBRAL GLUCOSE-METABOLISM; INTRANASAL INSULIN; MEMORY IMPAIRMENT; MOUSE MODEL; RECEPTOR SUBSTRATE; APOLIPOPROTEIN-E; NEURONAL DAMAGE; NERVOUS-SYSTEM;
D O I：
10.3390/ijms21093165
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
The exact connection between Alzheimer's disease (AD) and type 2 diabetes is still in debate. However, poorly controlled blood sugar may increase the risk of developing Alzheimer's. This relationship is so strong that some have called Alzheimer's "diabetes of the brain" or "type 3 diabetes (T3D)". Given more recent studies continue to indicate evidence linking T3D with AD, this review aims to demonstrate the relationship between T3D and AD based on the fact that both the processing of amyloid-beta (A beta) precursor protein toxicity and the clearance of A beta are attributed to impaired insulin signaling, and that insulin resistance mediates the dysregulation of bioenergetics and progress to AD. Furthermore, insulin-related therapeutic strategies are suggested to succeed in the development of therapies for AD by slowing down their progressive nature or even halting their future complications.
引用
收藏
页数：16
相关论文
共 105 条
  • [1] A Recent Update on the Effects of Omega-3 Fatty Acids in Alzheimer's Disease
    Ajith, Thekkuttuparambil Ananthanarayanan
    [J]. CURRENT CLINICAL PHARMACOLOGY, 2018, 13 (04): : 252 - 260
  • [2] Apelt J, 1999, J NEUROSCI RES, V57, P693, DOI 10.1002/(SICI)1097-4547(19990901)57:5<693::AID-JNR11>3.0.CO
  • [3] 2-X
  • [4] Flavonoids as Prospective Neuroprotectants and Their Therapeutic Propensity in Aging Associated Neurological Disorders
    Ayaz, Muhammad
    Sadiq, Abdul
    Junaid, Muhammad
    Ullah, Farhat
    Ovais, Muhammad
    Ullah, Ikram
    Ahmed, Jawad
    Shahid, Muhammad
    [J]. FRONTIERS IN AGING NEUROSCIENCE, 2019, 11
  • [5] Role of inflammatory molecules in the Alzheimer's disease progression and diagnosis
    Bagyinszky, Eva
    Vo Van Giau
    Shim, Kyuhwan
    Suk, Kyoungho
    An, Seong Soo A.
    Kim, SangYun
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 376 : 242 - 254
  • [6] Insulin Resistance and Alzheimer-like Reductions in Regional Cerebral Glucose Metabolism for Cognitively Normal Adults With Prediabetes or Early Type 2 Diabetes
    Baker, Laura D.
    Cross, Donna J.
    Minoshima, Satoshi
    Belongia, Dana
    Watson, Stennis
    Craft, Suzanne
    [J]. ARCHIVES OF NEUROLOGY, 2011, 68 (01) : 51 - 57
  • [7] The diabetes drug liraglutide reverses cognitive impairment in mice and attenuates insulin receptor and synaptic pathology in a non-human primate model of Alzheimer's disease
    Batista, Andre F.
    Forny-Germano, Leticia
    Clarke, Julia R.
    Lyra e Silva, Natalia M.
    Brito-Moreira, Jordano
    Boehnke, Susan E.
    Winterborn, Andrew
    Coe, Brian C.
    Lablans, Ann
    Vital, Juliana F.
    Marques, Suelen A.
    Martinez, Ana M. B.
    Gralle, Matthias
    Holscher, Christian
    Klein, William L.
    Houzel, Jean-Christophe
    Ferreira, Sergio T.
    Munoz, Douglas P.
    De Felice, Fernanda G.
    [J]. JOURNAL OF PATHOLOGY, 2018, 245 (01) : 85 - 100
  • [8] Aberrant insulin signaling in Alzheimer's disease: current knowledge
    Bedse, Gaurav
    Di Domenico, Fabio
    Serviddio, Gaetano
    Cassano, Tommaso
    [J]. FRONTIERS IN NEUROSCIENCE, 2015, 9
  • [9] Differential sensitivity of men and women to anorexigenic and memory-improving effects of intranasal insulin
    Benedict, Christian
    Kern, Werner
    Schultes, Bernd
    Born, Jan
    Hallschmid, Manfred
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2008, 93 (04) : 1339 - 1344
  • [10] An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer's disease-associated Aβ oligomers
    Bomfim, Theresa R.
    Forny-Germano, Leticia
    Sathler, Luciana B.
    Brito-Moreira, Jordano
    Houzel, Jean-Christophe
    Decker, Helena
    Silverman, Michael A.
    Kazi, Hala
    Melo, Helen M.
    McClean, Paula L.
    Holscher, Christian
    Arnold, Steven E.
    Talbot, Konrad
    Klein, William L.
    Munoz, Douglas P.
    Ferreira, Sergio T.
    De Felice, Fernanda G.
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2012, 122 (04) : 1339 - 1353
12345678910